Tom Video Thumbnail

Video: Nobel laureate Tom Cech still loves teaching

Oct. 15, 2018

CU Boulder's Tom Cech won the Nobel Prize for Chemistry in 1989, but he firmly believes his place is still in the classroom teaching undergraduates. Here, he discusses how teaching adds meaning to his life and how he still works to become a better teacher.

Daniel Youmans and Tom Cech

Researchers peer inside cells to spy on cancer's on-off switch

June 13, 2018

Medical student Daniel Youmans (left) and Tom Cech (right), director of the BioFrontiers Institute, look over an image from a high-powered microscope (Credit: Glenn Asakawa/CU Boulder) Forty years after researchers first discovered it in fruit flies, a once-obscure cluster of proteins called PRC2 has become a key target for new...

RNA splicing dance

Tom Cech leads RNA splicing dance

April 20, 2018

As part of BioFrontiers Institute Professor John Rinn’s biochemistry class, this week graduate students performed an RNA splicing interpretive dance on the west lawn of the Jennie Smoly Caruthers Biotech Building. CU Nobel Laureate and BioFrontiers Director Tom Cech (in the tie-dye T-shirt) played the starring role of the catalytic...

Participants of BizWest's CEO Roundtable on Life Sciences in Boulder are, from left, Misha Plam, Ron Squarer, David Kerr, William Marshall, Chris Shapard, Jennifer Jones, Tin Tin Su, Pawel Fludzinski, Amy Beckley, Tom Cech, Becky Potts, Kyle Lefkoff, Tom Hertzberg, Jonathan Vaught, Marvin Caruthers, Not pictured: Brynmor Reese. BizWest/Jensen Werley.

Boulder’s bioscience industry growing to critical mass

April 18, 2018

After years of companies being sold off or growing and relocating, Boulder’s life-sciences sector is showing signs of reaching critical mass. Companies such as Clovis Oncology Inc. (Nasdaq: CLVS), SomaLogic Inc., Array Biopharma Inc. (Nasdaq: ARRY) and miRagen Therapeutics Inc. (Nasdaq: MGEN) are showing that homegrown businesses can continue to...

X

Nobel Laureate gives 2017 Herchel Smith Lecture

Oct. 9, 2017

Nobel Laureate Professor Tom Cech came to the Department of Chemistry on 16th October, to give the 2017 Herchel Smith Lecture: 'Shedding some Light on the Dark Matter of the Genomic Universe.' Professor Cech is Distinguished Professor at the University of Colorado Boulder, Director of the University of Colorado BioFrontiers...

Distinguished Professor Tom Cech. Photo: Glenn Asakawa / University of Colorado Boulder.

Nobel laureate Tom Cech wins 2017 Hazel Barnes Prize

March 24, 2017

University of Colorado Boulder Distinguished Professor Tom Cech, Colorado’s first Nobel Prize winner, has been named the 2017 Hazel Barnes Prize winner – the most distinguished award a faculty member can receive from the university. Cech, the director of the BioFrontiers Institute , shared the 1989 Nobel Prize in Chemistry...

Tom Cech's lab is focused, in part, on studying telomerase: a powerful enzyme found at the ends of chromosomes.

Live Cells reveal cancer process

Aug. 11, 2016

A deep look inside the live cells reveals a key cancer process Telomerase, a powerful enzyme found at the ends of chromosomes, can keep humans healthy, or promote cancer growth. Researchers at the University of Colorado in Boulder used a process called single-molecule imaging to look into the complicated processes...

John Milligan – photo courtesy of Gilead Sciences

Continuing a bioscience legacy at CU Boulder

Aug. 1, 2016

John Milligan spent two years at the University of Colorado Boulder during his graduate studies in the mid-1980’s. He helped to move his mentor, Dr. Olke Uhlenbeck, in a U-Haul truck across the Great Plains to the Rockies. Uhlenbeck was recruited from the University of Illinois in 1986 to head...

Telomeres sit at the ends of chromosomes to protect their genetic data (colorful DNA pic) Credit: Jane Ades, NHGRI

Research on small cellular changes may lead to big cancer solutions

March 10, 2015

Among cancers, scientists have spent their entire research careers looking for cellular similarities that may lead to a single cure for many cancers –– the rare chance to have a single answer to a multifaceted problem. In 1997, scientists discovered a gene that they believed was the key to cellular...

Telomeres sit at the ends of chromosomes to protect their genetic data. Credit: Jane Ades, NHGRI

BioFrontiers researchers uncover new target for cancer research

Oct. 24, 2012

In a new paper released today in Nature , BioFrontiers Institute scientists at the University of Colorado in Boulder, Tom Cech and Leslie Leinwand, detailed a new target for anti-cancer drug development that is sitting at the ends of our DNA. Researchers in the two scientists’ laboratories collaborated to find...

Pages